This evidence demonstrates that combined inhibitions of CHK1 and RAD51 and of CHK1 and MRE11 in RES-CRC-SCs not only affect DNA replication but also deregulate cell cycle proliferation and mitotic timing. The gene discussed is RAD51; the disease is colorectal carcinoma.